Significance of Japanese Kampo Medicine in Supportive Care of Heart Failure/Function

Darukeshwara Joladarashi, Rajarajan A. Thandavarayan, Prasanna Krishnamurthy

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Heart failure (HF) accounts for about 23. million patients worldwide. Diagnosing HF in patients is still poor and a prospective approach to prevent and treat HF is essential. In Japan, the number of HF patients has been growing since 1950, chiefly due to a swiftly aging population. In addition, diminished physical activity, a Westernized dietary pattern, and obesity have become conspicuous, mainly in younger Japanese men. Intensifying inclination toward diabetes and dyslipidemia and the prevalence of smoking and hypertension remain high. Japan's medical care is recognized for the ability to access both Kampo and Western medical care at the same time. There have been many publications based on studies that demonstrate analgesic or supportive care for cardiac function using Kampo preparations. In this chapter, we summarize the use of traditional therapeutic Kampo formulations for supportive cardiac care in Japan.

Original languageEnglish (US)
Title of host publicationJapanese Kampo Medicines for the Treatment of Common Diseases
Subtitle of host publicationFocus on Inflammation
PublisherElsevier
Pages47-57
Number of pages11
ISBN (Electronic)9780128094440
ISBN (Print)9780128093986
DOIs
StatePublished - Mar 23 2017

Keywords

  • Diagnosis
  • Heart failure
  • Herbal drugs
  • Kampo medicine
  • Public health

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Fingerprint Dive into the research topics of 'Significance of Japanese Kampo Medicine in Supportive Care of Heart Failure/Function'. Together they form a unique fingerprint.

Cite this